# Systematic profiling of SARS-CoV-2 structural protein-specific T cell epitopes in Omicron infections following inactivated vaccination

**Authors:** Zhiqing Li, Mengmeng Cui, Jian Wu, Tianju Hu, Junyan Dan, Xiaosu Chen, Qicong Shen, Jin Hou, Zhongfang Wang, Yizhi Yu, Shuxun Liu

PMC · DOI: 10.1016/j.isci.2026.114891 · iScience · 2026-02-03

## TL;DR

The study identifies key T cell epitopes in SARS-CoV-2 Omicron infections after inactivated vaccination, highlighting conserved immune responses and potential vaccine targets.

## Contribution

The work systematically identifies immunodominant T cell epitopes and their HLA associations in vaccinated individuals infected with Omicron, revealing conserved epitopes across variants.

## Key findings

- Inactivated vaccination primes CD4+ T cells for conserved epitopes in S1-NTD, M protein β-sandwich, and N-CTD.
- XBB.1.5 and BA.2.86 mutations partially evade T cell immunity but a conserved HLA-DRB1∗09:01 epitope remains effective.
- Epitope-specific T cell responses show variable durability over 10 months post-infection.

## Abstract

Comprehensive identification of T cell epitopes is crucial for understanding SARS-CoV-2-specific T cell immunity and guiding vaccine development. Epitope-specific T cells primed by inactivated vaccination (IV)—widely administered in China—followed by Omicron breakthrough infection (BI)—remain poorly characterized. Using hierarchical epitope screening in the IV-BI cohort, we systematically validated known epitope-HLA interactions and uncovered previously unrecognized associations, revealing immunodominant epitopes in conserved regions (S1-NTD, M protein β-sandwich, and N-CTD). Based on these epitopes, analysis of cohort samples before and after BI revealed that certain epitope-specific, CD4+ T cells were initially primed by IV. Longitudinal analysis revealed epitope-specific temporal dynamics in SARS-CoV-2-specific T cell immunity, with certain subsets declining over 10 months post-infection. While XBB.1.5 and BA.2.86 subvariant-harboring mutations partially evaded T cell immunity, a conservative HLA-DRB1∗09:01-restricted epitope was identified across ancestral and Omicron strains. These findings delineate regionally prevalent HLA-associated immunodominant epitope frameworks and highlight pan-variant epitope candidates for vaccine development and T cell immunity monitoring.

•Characterizing dominant HLA-epitope pairs by inactive vaccine and Omicron infection•Inactive vaccination elicits broad-spectrum CD4+ T but not CD8+ T cell response•Mutated S152–160, S360–370, and S126–140 in XBB.1/BA2.86 variant impair T cell recognition•SARS-CoV-2 T cell clones show varying durability based on epitopes

Characterizing dominant HLA-epitope pairs by inactive vaccine and Omicron infection

Inactive vaccination elicits broad-spectrum CD4+ T but not CD8+ T cell response

Mutated S152–160, S360–370, and S126–140 in XBB.1/BA2.86 variant impair T cell recognition

SARS-CoV-2 T cell clones show varying durability based on epitopes

Molecular biology; Immunology; Virology

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** MICA (MHC class I polypeptide-related sequence A) [NCBI Gene 100507436] {aka MIC-A, PERB11.1}, HLA-F (major histocompatibility complex, class I, F) [NCBI Gene 3134] {aka CDA12, HLA-5.4, HLA-CDA12, HLAF}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106] {aka AS, B-4901, HLAB}, KLRB1 (killer cell lectin like receptor B1) [NCBI Gene 3820] {aka CD161, CLEC5B, NKR, NKR-P1, NKR-P1A, NKRP1A}, PSORS1C1 (psoriasis susceptibility 1 candidate 1) [NCBI Gene 170679] {aka C6orf16, SEEK1}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123] {aka DRB1, HLA-DR1B, HLA-DRB, SS1}, MYOM2 (myomesin 2) [NCBI Gene 9172] {aka TTNAP}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, N (nucleocapsid phosphoprotein) [NCBI Gene 43740575], CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, HLA-DPB1 (major histocompatibility complex, class II, DP beta 1) [NCBI Gene 3115] {aka DPB1, HLA-DP, HLA-DP1B, HLA-DPB}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, M (membrane glycoprotein) [NCBI Gene 43740571], CXCR5 (C-X-C motif chemokine receptor 5) [NCBI Gene 643] {aka BLR1, CD185, MDR15}, CD27 (CD27 molecule) [NCBI Gene 939] {aka S152, S152. LPFS2, T14, TNFRSF7, Tp55}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** autoimmune inflammatory disorders (MESH:D007249), uveitis (MESH:D014605), autoimmune (MESH:D001327), BD (MESH:D001528), genital ulcers (MESH:D014456), COVID-19 (MESH:D000086382), infection (MESH:D007239), viral infections (MESH:D014777), occlusive vasculopathy (MESH:D001157), infectious disease (MESH:D003141), aphthous ulcers (MESH:D013281), BI (MESH:D000093742)
- **Chemicals:** nitrogen (MESH:D009584), brefeldin A (MESH:D020126), D-biotin (MESH:D001710), peptides (MESH:D010455), amine (MESH:D000588), 1xPBS (-), Cy5 (MESH:C085321), DMSO (MESH:D004121), PBS (MESH:D007854), CO2 (MESH:D002245)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** L368I, V127F, D614G, R158G, L452R, S50L, F157S

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927107/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927107/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927107/full.md

---
Source: https://tomesphere.com/paper/PMC12927107